Drug delivery, formulation

People on the Move: January 2022

06-Jan-2022 By Jenni Spinner

This month’s news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

Resilience, collaboration can drive pharma innovation: IFF

03-Jan-2022 By Jenni Spinner

A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.

Integrated development models key to supply chain success: Lonza

03-Jan-2022 By Jenni Spinner

An R&D leader from Lonza explains its proactive approach to staying on top of supply chain challenges, including a new dedicated manufacturing line in China.

Novo Nordisk weight-management treatment hits supply snag

20-Dec-2021 By Jenni Spinner

The pharmaceutical company has announced GMP-related challenges with a manufacturer contracted to fill syringes for Wegovy pens headed to the US market.

Insilico Medicine launches trial for AI-discovered drug

15-Dec-2021 By Jenni Spinner

The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis.

ASH 2021 sees Novartis launch a 'next-generation' CAR-T platform

14-Dec-2021 By Jane Byrne

Novartis has introduced its T-Charge platform at ASH 2021, which it says will serve as the foundation for various new investigational CAR-T cell therapies in its pipeline.

Roquette plans to open doors of new US innovation center

08-Dec-2021 By Jenni Spinner

Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

GSK and University of Oxford launch new institute, embracing advanced technologies for drug discovery

02-Dec-2021 By Rachel Arthur

The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.

AstraZeneca opens new advanced therapeutics R&D facility in Cambridge

23-Nov-2021 By Jane Byrne

AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.

FDA approves BioMarin drug to treat dwarfism in children

22-Nov-2021 By Jenni Spinner

The US agency has granted approval to Voxzogo, an injectable drug designed to aid growth in children with achondroplasia, the most common form of dwarfism.

TFF completes dosing in Phase Ib clinical study for asthma drug

15-Nov-2021 By Jenni Spinner

The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.

Biohaven wraps patient enrollment for ALS clinical trial arm

15-Nov-2021 By Jenni Spinner

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

Baxter investing $100m to bolster German sterile fill/finish facility

11-Nov-2021 By Jenni Spinner

The infusion of funds in the Halle/Westfalen, Germany manufacturing complex is intended to help meet growing global demand for injectable pharmaceuticals.

cphi worldwide

Variable-dose pen injector platform designed for simple use

11-Nov-2021 By Jenni Spinner

Stevanato Group is showcasing its SG Alina disposable, variable-dose pen injector platform, available with customizable features, at CPhI Worldwide 2021.

Novartis to sell its stake in Roche to Roche for $20.7bn

04-Nov-2021 By Rachel Arthur

Novartis, which has been a shareholder in Roche for more than 20 years, will sell its stake in the business to Roche for $20.7bn.

CPHI WORLDWIDE

Carrier solution addresses challenging liquid APIs: W.R. Grace

03-Nov-2021 By Jenni Spinner

The CPhI Worldwide exhibitor will show Syloid XDP, a silica carrier designed to convert liquid, waxy, or oily active ingredients into free-flowing powders.

From the show floor: Exhibitors at CPhI Worldwide 2021

03-Nov-2021 By Rachel Arthur

CPhI Worldwide welcomes attendees back to the show floor in person this month. We put the spotlight on some of the exhibitors who will be there.

CPhI Worldwide

Gerresheimer develops delivery device for drugs with higher viscosity

03-Nov-2021 By Jane Byrne

CPhI Worldwide will see Gerresheimer showcase its latest developments in primary packaging, drug delivery systems for newly developed biologics along with medical and diagnostic products.

CPhI Worldwide

Excipients play key role in pharmaceutical innovation: Croda

02-Nov-2021 By Jenni Spinner

An expert from the specialty chemicals firm (and CPhI Worldwide speaker) explains trends and developments in excipients and how they drive advancements.

CPHI WORLDWIDE

Hybrid CPhI Worldwide 2021 a ‘celebration’ of pharma industry

02-Nov-2021 By Jenni Spinner

The global pharmaceutical industry event is returning to the real world November 9-11 this year, with online content for professionals opting not to travel.

Potential COVID-19 treatment to wrap up Phase III trial

26-Oct-2021 By Jenni Spinner

Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.

AAPS PharmSci 360

PharmSci 360 invites industry pros to ‘rethink and evolve’

14-Oct-2021 By Jenni Spinner

The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.

CytoReason, Summit tap into AI on Japanese drug development effort

12-Oct-2021 By Jenni Spinner

The AI technology firm and pharma services company are joining to help one of the country’s leading pharmaceutical firms develop a promising drug candidate.

ViiV submits FDA application for pediatric HIV treatment

07-Oct-2021 By Jenni Spinner

The HIV treatment specialist has sent an application to the agency for tolutegravir, a single-tablet treatment indicated for children living with the virus.

People on the Move: October 2021

07-Oct-2021 By Jenni Spinner

This month’s news on appointments, expansions, acquisitions and other events includes Nanoform, Elligo Health Research, Curavit, and other organizations.

Doctors believe in immunotherapy’s cancer-fighting potential: BMS survey

14-Sep-2021 By Jenni Spinner

A survey commissioned by Bristol Myers Squibb reveals healthcare providers are confident that immunotherapy can positively impact earlier-stage cancers.

3D tablet printing needs the right excipient: DFE Pharma

18-Aug-2021 By Jenni Spinner

The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.

SPI launches UltraBurst excipient designed for ODT formulation

18-Aug-2021 By Jenni Spinner

The pjarmaceutical excipient, intended for use in the formulation of flash orally dissolving tablets, is designed to disintegrate in less than 10 seconds.

Orally disintegrating tablets offer range of patient benefits: Roquette

18-Aug-2021 By Jenni Spinner

A leader from the excipients firm discusses how ODTs appeal to seniors and patients on the go, and the formulation-related challenges with such tablets.

Virtual reality technology transforming COVID-19 drug discovery

09-Aug-2021 By Jenni Spinner

Nanome’s virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.

mRNA and beyond: Opportunities for US biologics

03-Aug-2021 By Staff reporter

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

BMS, BridgeBio partner to study drug combo for lung cancer

27-Jul-2021 By Jenni Spinner

The two pharma firms will partner to study the efficacy of Opdivo, paired with a SHP2 inhibitor, to treat non-small cell lung cancer with KRAS mutations.

Wave of acquisitions hits pharma industry this week

15-Jul-2021 By Jenni Spinner

The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.

Tech Innovations: June 2021

23-Jun-2021 By Jenni Spinner

This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.

DIA 2021 Annual Meeting

‘Magic happens’ when pharma pros meet to share ideas: DIA

16-Jun-2021 By Jenni Spinner

A leader with the association discusses the value in attending events like the DIA 2021 Annual Meeting gather to tackle COVID-19 and other challenges.

Optimizing tablet manufacturing complex but vital: I Holland

08-Jun-2021 By Jenni Spinner

A leader from the manufacturing technology provider talks about how companies can work to streamline oral solid dose manufacturing to remain competitive.

Cognizant pharmacovigilance services land top industry marks

18-May-2021 By Jenni Spinner

A report by analyst outfit Everest Group revealed in a survey, industry professionals awarded the company’s pharma safety services favorable reviews.

Novasep expands in France, sees increasing customer demand for ADC manufacturing services

14-May-2021 By Jane Byrne

Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities at its Le Mans, France site, saying the move strengthens its position as a leading CDMO for the production of innovative...

Drug developer uses RWE to research psychedelic therapies

13-May-2021 By Jenni Spinner

The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions.

Lonza leader outlines small-molecule trends for 2021 and beyond

06-May-2021 By Jenni Spinner

The head of small-molecule business for the pharma solutions specialist talks about obstacles, and how companies can work to clear them for future success.

Nanoform, Aprecia partner on 3D-printed nanomedicines

27-Apr-2021 By Jenni Spinner

The two companies plan to collaboratively explore ways to combine 3D printing and nanotechnology, in order to create nanoparticle-enabled dosage forms.

Cyclica teams with academics to investigate COVID-19 treatment

14-Apr-2021 By Jenni Spinner

The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatment’s potential in treating COVID-19.

Report reveals gap between rare-disease drug spending, need

11-Mar-2021 By Jenni Spinner

The IQVIA and NORD study shows rare-disease treatments account for only 11% of new drug spending, but 80% of orphan products treat rare diseases alone.

Setback for Novartis drug in advanced lung cancer trial

09-Mar-2021 By Jane Byrne

Novartis reported today that a clinical trial of the drug, known as canakinumab, when combined with chemotherapy agent, docetaxel, failed to extend the lives of patients with advanced or metastatic non-small cell lung cancer compared to just chemotherapy...

Connect 2 Cleanrooms builds temporary unit for NHS Wales COVID response

09-Mar-2021 By Jenni Spinner

The temporary medicines unit built for the agency's Central Intravenous Additive Service can produce up to 2,600 syringes weekly to meet growing demand

Prostate cancer drug demonstrates major survival benefit

02-Mar-2021 By Jenni Spinner

According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer.

FDA approves injectable treatment for HIV patients

25-Jan-2021 By Jenni Spinner

The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.

Grifols to launch trial for potential COVID-19 therapy

19-Jan-2021 By Jenni Spinner

The subcutaneously administered immunoglobulin, if successful, would provide rapid immunity against the virus behind the deadly global pandemic.

Repurposing existing drugs accelerates discovery: XenoTech

12-Jan-2021 By Jenni Spinner

Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.

Ingredients, innovation and a need for speed: what’s in store for 2021

23-Dec-2020 By Jenni Spinner

Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.